LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

BACKGROUND: RSV-associated acute respiratory infections (ARI), particularly lower respiratory tract diseases (LRTD), present a significant disease burden in older adults. Currently, there are no approved vaccines against RSV. We present results from an ongoing study designed to demonstrate the vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ison, Michael G, Papi, Alberto, Langley, Joanne M, Lee, Dong-Gun, Leroux-Roels, Isabel, Martinon-Torres, Federico, Schwarz, Tino F, Van Zyl-Smit, Richard N, Dezutter, Nancy, De Schrevel, Nathalie, Fissette, Laurence, David, Marie-Pierre, Van Der Wielen, Marie, Kostanyan, Lusine, Hulstrøm, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752764/
http://dx.doi.org/10.1093/ofid/ofac492.1868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752764/
http://dx.doi.org/10.1093/ofid/ofac492.1868

Ejemplares similares